Murine antibody against E2 can capture hepatitis C virus in vitro

被引:0
作者
Ma, WB [1 ]
Feng, BF [1 ]
Tao, QM [1 ]
机构
[1] Beijing Univ, Peoples Hosp, Inst Hepatol, Beijing 100044, Peoples R China
关键词
hepatitis C virus; neutralizing antibody; envelop protein;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To find neutralizing antibody candidates against hepatitis C virus (HCV) infection. Methods We constructed two eukaryotic expression vectors which contained the E1 and E2 gene of HCV, and detected their expression in mammalian cells with transient expression. BALB/c mice were given subculaneous injections of constructed vectors combined with the IL-2 gene intraepidermally and evaluated for induced humoral immune responses by enzyme-linked immunosorbent assay (ELISA). We used an antibody-virus interaction assay to analyze the interaction of the antisera and HCV viral particles in vitro. Results Anti E1 and anti-E2 antisera were obtained from immunized mice. The serum of mice immunized with the E2 gene immunoprecipitated the HCV isolate in source serum and reacted with the isolates unrelated to the original one. Conclusions Anti-E2 antibody in induced mice can cross-reactively capture HCV particles, highlighting the possibility of generating broadly reactive anti-E2 antibodies.
引用
收藏
页码:860 / 863
页数:4
相关论文
共 9 条
[1]   Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein [J].
Farci, P ;
Shimoda, A ;
Wong, D ;
Cabezon, T ;
DeGioannis, D ;
Strazzera, A ;
Shimizu, Y ;
Shapiro, M ;
Alter, HJ ;
Purcell, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (26) :15394-15399
[2]  
GAO JN, 1999, J BEIJING MED U, V31, P113
[3]   EQUILIBRIUM CENTRIFUGATION STUDIES OF HEPATITIS-C VIRUS - EVIDENCE FOR CIRCULATING IMMUNE-COMPLEXES [J].
HIJIKATA, M ;
SHIMIZU, YK ;
KATO, H ;
IWAMOTO, A ;
SHIH, JW ;
ALTER, HJ ;
PURCELL, RH ;
YOSHIKURA, H .
JOURNAL OF VIROLOGY, 1993, 67 (04) :1953-1958
[4]  
MA WB, 2000, NATL MED CHIN CHIN, V80, P383
[5]   A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures [J].
Shimizu, YK ;
Igarashi, H ;
Kiyohara, T ;
Cabezon, T ;
Farci, P ;
Purcell, RH ;
Yoshikura, H .
VIROLOGY, 1996, 223 (02) :409-412
[6]   NEUTRALIZING ANTIBODIES AGAINST HEPATITIS-C VIRUS AND THE EMERGENCE OF NEUTRALIZATION ESCAPE MUTANT VIRUSES [J].
SHIMIZU, YK ;
HIJIKATA, M ;
IWAMOTO, A ;
ALTER, HJ ;
PURCELL, RH ;
YOSHIKURA, H .
JOURNAL OF VIROLOGY, 1994, 68 (03) :1494-1500
[7]  
TAKAFUMI ST, 1997, GASTROENTEROLOGY, V112, P1321
[8]  
TAKASHI YK, 1985, P NATL ACAD SCI USA, V82, P68
[9]   PREVALENCE, GENOTYPES, AND AN ISOLATE (HC-C2) OF HEPATITIS-C VIRUS IN CHINESE PATIENTS WITH LIVER-DISEASE [J].
WANG, Y ;
OKAMOTO, H ;
TSUDA, F ;
NAGAYAMA, R ;
TAO, Q ;
MISHIRO, S .
JOURNAL OF MEDICAL VIROLOGY, 1993, 40 (03) :254-260